Leaders protest recent decision to deny Medicare beneficiaries coverage of amyloid scans.
Update on compounds in Phase 2 and 3 trials from the Alzheimer's Association International Conference
Speakers at Alzheimer’s conference reviewed planned Phase 1 and prevention trials and preclinical studies.
Studies reported at AAIC demonstrate that biomarkers help predict who will develop cognitive impairment and dementia.
Researchers at AAIC 2013 report that an individual’s subjective sense of worsening memory could be an important predictor of cognitive impairment and dementia.
This scientific meeting that drew some 150 researchers to San Francisco 15-17 April 2013 featured an unusually broad array of topics...
A small panel of fluid biomarkers could predict a slow or fast disease course in amyotrophic lateral sclerosis.
With variants that boost risk for both familial and sporadic Parkinson’s disease, the LRRK2 gene beckons as a prime target for therapy development...